Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jul 1, 2022	Jul 1, 2021
Market Capitalization	1,429	1,522	1,546	1,975	2,036	2,186
Market Cap Growth	35.16%	-1.50%	-21.77%	-2.97%	-6.88%	-1.96%
Enterprise Value	1,446	1,544	1,570	2,047	2,079	2,262
Last Close Price	12.30	13.08	13.27	16.96	17.75	18.68
PE Ratio	-	-	-	234.98	80.87	16.23
PS Ratio	7.22	8.27	8.75	5.28	4.20	2.80
PB Ratio	0.98	1.05	0.98	1.22	1.25	1.35
P/TBV Ratio	0.98	1.05	0.98	1.22	1.25	1.35
P/FCF Ratio	21.43	26.30	65.38	46.03	42.77	-
P/OCF Ratio	21.25	26.05	45.77	27.08	23.33	14.48
EV/Sales Ratio	7.30	8.38	8.89	5.47	4.29	2.89
EV/EBITDA Ratio	169.02	350.91	328.22	30.53	27.74	10.81
EV/EBIT Ratio	-	-	-	71.35	58.07	13.05
EV/FCF Ratio	21.67	26.67	66.42	47.69	43.67	-
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.05	0.05
Debt / EBITDA Ratio	4.55	4.55	5.06	0.65	1.01	0.41
Debt / FCF Ratio	0.35	0.35	1.02	1.02	1.58	-
Asset Turnover	0.10	0.10	0.10	0.20	0.26	0.43
Inventory Turnover	1.23	1.23	0.92	1.55	1.76	2.39
Quick Ratio	1.71	1.71	2.12	1.88	1.61	1.65
Current Ratio	3.62	3.62	4.95	4.26	3.50	3.57
Return on Equity (ROE)	-2.43%	-2.43%	-2.56%	0.52%	1.55%	8.57%
Return on Assets (ROA)	-0.85%	-0.85%	-0.80%	0.95%	1.18%	5.95%
Return on Invested Capital (ROIC)	-1.58%	-1.57%	-1.46%	0.59%	1.70%	8.45%
Return on Capital Employed (ROCE)	-1.50%	-1.50%	-1.40%	1.60%	2.10%	10.00%
Earnings Yield	-2.28%	-2.42%	-2.65%	0.43%	1.24%	6.16%
FCF Yield	4.67%	3.80%	1.53%	2.17%	2.34%	-2.26%
Dividend Yield	0.12%	0.11%	0.07%	-	0.56%	2.14%
Payout Ratio	-	-	-	123.72%	98.46%	19.97%
Buyback Yield / Dilution	-	-	-	-	-2.17%	-
Total Shareholder Return	0.12%	0.11%	0.07%	-	-1.61%	2.14%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.